Lacey Thompson, PA
Physician Assistant · Dickson, TNNPI 1366965287
Payments from drug & device makers
Across 228 payments — averaging $14.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$493
- AbbVie$375
- GSK$237
- Optinose US, Inc.$233
- Takeda Pharmaceuticals U.S.A., Inc.$210
- Boehringer Ingelheim$171
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 46 | $493 |
| AbbVie | 34 | $375 |
| GSK | 17 | $237 |
| Optinose US, Inc. | 17 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $210 |
| Boehringer Ingelheim | 14 | $171 |
| Clarus Therapeutics Inc. | 6 | $162 |
| Amgen | 8 | $136 |
| Amarin Pharma, Inc. | 11 | $126 |
| Bayer | 6 | $103 |
| Lilly USA, LLC | 6 | $86 |
| AstraZeneca | 6 | $77 |
| Novartis | 4 | $75 |
| Pfizer | 5 | $66 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Johnson & Johnson | 4 | $57 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Astellas Pharma US Inc | 4 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Stryker | 2 | $43 |
| Boston Scientific | 1 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Smith+Nephew | 1 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Eisai Inc. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Merck | 1 | $16 |
| Scynexis, Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
| Adlon Therapeutics L.p. | 1 | $11 |
How this compares
$3,196 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 213 | $2,244 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $1,912 |
| Mometasone Furoate | 63 | $923 |
| Cefdinir | 56 | $836 |
| Ofloxacin | 31 | $834 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 12 | $612 |
| Prednisone | 214 | $579 |
| Azelastine Hcl | 17 | $564 |
| Ipratropium Bromide | 23 | $516 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $492 |
| Methylprednisolone | 59 | $485 |
| Pantoprazole Sodium | 43 | $412 |
| Ciprofloxacin Hcl | 27 | $258 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $211 |
| Celecoxib | 14 | $204 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Dickson
- Jeffrey NortonDickson$59K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.